On-X Life Technologies, Inc. Announces Results Of Its On-X Anticoagulation Clinical Trial (PROACT)

Read about howe On-X Life Technologies, Inc. Announces the Results Of Its On-X Anticoagulation Clinical Trial (PROACT).

http://bionews-tx.com/news/2013/05/07/on-x-life-technologies-inc-announces-results-of-its-on-x-anticoagulation-clinical-trial-proact/

Austin’s Benchmark Research Honored With Industry Accolades For Excellence In Operations, Vaccines

The Austin-based Benchmark Research has recently received prestigious accolades from two prestigious associations. Both the Association of Clinical Research Professionals (ACRP) and the World Vaccine Congress (WVC), acknowledged the company at their annual conferences last week.

http://bionews-tx.com/news/2013/05/02/austins-benchmark-research-honored-with-industry-accolades-for-excellence-in-operations-vaccines/

Novum Opening State-of-the-Art Clinical Research Facility in Houston

Novum Pharmaceutical Research Services, a leading contract research organization, will open a 55,000 square foot facility in Houston by August of 2013.

http://bionews-tx.com/news/2013/04/05/novum-opening-state-of-the-art-clinical-research-facility-in-houston/

Texas Children’s Hospital Resident Awarded Genzyme/ACMG Foundation Training Award in Clinical Biochemical Genetics

Read about how a Texas Children’s Hospital Resident was Awarded Genzyme/ACMG Foundation Training Award in Clinical Biochemical Genetics.

http://bionews-tx.com/news/2013/03/29/texas-childrens-hospital-resident-awarded-genzymeacmg-foundation-training-award-in-clinical-biochemical-genetics/

Biopharmaceutical Clinical Trials of Medicines Boost Texas Economy; Benefit Patients

Biopharmaceutical Clinical Trials of Medicines Boost Texas Economy; Benefit Patients

http://bionews-tx.com/news/2013/03/26/biopharmaceutical-clinical-trials-of-medicines-boost-texas-economy-benefit-patients/